Mirae Asset Global Etfs Holdings Ltd. Century Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,447 shares of IPSC stock, worth $17,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,447
Previous 26,277
4.45%
Holding current value
$17,291
Previous $26,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IPSC
# of Institutions
72Shares Held
27.4MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.41 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$2.02 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.82 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.57 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.5 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $37.1M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...